Onconetix Inc (ONCO)
1.64
-0.08
(-4.65%)
USD |
NASDAQ |
Nov 14, 16:00
1.74
+0.10
(+6.10%)
After-Hours: 19:49
Onconetix Gross Profit Margin (Quarterly): 14.29% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 14.29% |
| Date | Value |
|---|---|
| March 31, 2024 | 26.98% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
14.29%
Minimum
Jun 2024
26.98%
Maximum
Mar 2024
20.64%
Average
20.64%
Median
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 84.00% |
| IGC Pharma Inc | 59.93% |
| NovaBay Pharmaceuticals Inc | 66.33% |
| Protalix BioTherapeutics Inc | 29.82% |
Gross Profit Margin (Quarterly) Related Metrics
| Profit Margin (Quarterly) | -2.03K% |
| Operating Margin (Quarterly) | -300.3% |